L'Oreal Settles First Hair Relaxer Cancer Trial in Chicago
L'Oreal's US unit settled the first hair relaxer cancer trial in Chicago on Nov. 16 for a confidential sum, with more than 12,700 federal cases still pending.
Topic
Topic
L'Oreal's US unit settled the first hair relaxer cancer trial in Chicago on Nov. 16 for a confidential sum, with more than 12,700 federal cases still pending.